top of page
![I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics [...]](https://static.wixstatic.com/media/e4cf23_684190d40e314e55a7c7bac29faebe20~mv2.jpg/v1/fill/w_1072,h_804,fp_0.50_0.50,q_90,enc_auto/e4cf23_684190d40e314e55a7c7bac29faebe20~mv2.jpg)
31 mars 2023
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics [...]
Peyrin-Biroulet L, Rahier J-F, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, et al. Original Article in Clinical Gastroenterology and...
![P509 IBD cancer and serious infections in Europe (I-CARE): a European prospective [...]](https://static.wixstatic.com/media/cc33194e92ac493c81a5d60306500ac3.jpg/v1/fill/w_1072,h_804,fp_0.50_0.50,q_90,enc_auto/cc33194e92ac493c81a5d60306500ac3.jpg)
26 janv. 2017
P509 IBD cancer and serious infections in Europe (I-CARE): a European prospective [...]
Background: Prospective studies specifically assessing the effectiveness and safety profile of current therapeutic strategies based on a ...
10 mars 2016
GETAID | I-CARE | MICI | e-cohorte | Europe
I-CARE est une étude observationnelle du GETAID visant à évaluer l'efficacité et la sécurité des immunomodulateurs, des anti-TNF ou du ...
bottom of page